Lockheed Martin Corp/ US5398301094 /
20.05.2024 22:10:00 | Изменение +0.88 | Объем сделки | Бид13:00:05 | Предложение13:00:05 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
467.08USD | +0.19% | 735,291 Оборот: 182.55 млн |
463.00Величина цены спроса: 100 | 469.66Величина цены предложения: 200 | 112.07 млрдUSD | 2.60% | 16.89 |
GlobeNewswire
13:15
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
13:10
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
13:07
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
13:05
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
13:00
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
13:00
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
13:00
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
13:00
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
13:00
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
13:00
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
13:00
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
13:00
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница